莱美药业 (300006.SZ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

财务分析(报告期)(莱美药业)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年一季报2023年年报2023年三季报2023年中报2023年一季报2022年年报2022年三季报2022年中报2022年一季报
主要指标:
 营业收入(元) 181,120,476.19895,592,665.42644,756,058.18453,859,975.46226,654,528.42884,586,776.10670,853,551.45406,431,569.23198,706,756.18
 营业利润(元) 1,807,967.8056,226,689.00-12,795,553.21-14,453,399.44-3,235,229.19-96,039,724.49-66,999,884.21-60,654,925.12-27,783,130.19
 利润总额(元) 1,768,540.493,594,339.63-64,995,941.52-66,492,163.89-3,300,948.23-75,248,021.16-46,070,929.86-60,702,829.37-27,815,470.95
 净利润(元) 31,378.00-10,017,779.10-63,966,209.62-63,057,873.43-7,606,050.33-76,286,148.74-44,728,469.91-54,793,017.86-28,991,013.48
 归属于母公司股东的净利润(元) -4,575,299.38-8,927,328.47-54,513,800.64-54,056,871.17-3,634,060.91-68,709,119.36-37,373,010.95-49,071,727.55-26,403,512.18
盈利能力:
 销售毛利率(%) 64.8269.3369.2769.9870.7873.5073.3471.6373.33
 销售净利率(%) 0.02-1.12-9.92-13.89-3.36-8.62-6.67-13.48-14.59
 净资产收益率(%) -0.22-0.42-2.59-2.59-0.17----
 总资产报酬率ROA(%) -0.12-0.64-2.81-2.71-0.21----
 投入资本回报率ROIC(%) -0.19-0.37-2.25-2.24-0.15-2.84-1.54-2.03-1.09
营运能力:
 存货周转率(次) 0.341.471.150.700.36----
 应收账款周转率(次) 0.502.741.951.330.61----
 总资产周转率(次) 0.060.300.220.150.07----
偿债能力:
 资产负债率(%) 28.7026.5927.2427.9629.2628.4827.4328.1727.45
 股东权益比率(%) 69.7571.9771.6570.9568.8469.5470.4470.1270.80
 已获利息倍数(倍) 0.670.844.575.862.11-14.65212.93-166.80-14,967.80
 流动比率 2.592.932.822.532.452.492.722.852.81
 速动比率 2.262.572.472.182.152.142.422.502.50
发展能力:
 营业收入增长率(%) -20.091.24-3.8911.6714.06-27.80-24.77-33.59-44.85
 营业利润增长率(%) 155.88158.5580.9076.1788.36-36.92-360.53-254.58-144.09
 税后利润增长率(%) -25.9087.01-45.86-10.1686.2431.65-287.15-251.49-153.99
 净资产增长率(%) -2.21-2.06-3.17-1.66-0.33-1.48-5.48-7.43-7.11
 总资产增长率(%) -3.48-5.38-4.81-2.822.514.381.97-2.84-17.87

前瞻产业研究院